Lionheart Health, Inc., a company specializing in bioelectric regenerative medicine, announced that Dr. Joseph C. Maroon has joined its Scientific and Clinical Advisory Board. Dr. Maroon is a board-certified neurosurgeon, Clinical Professor of Neurosurgery at the University of Pittsburgh Medical Center, and has served as Team Neurosurgeon for the Pittsburgh Steelers for decades. His expertise in brain health, concussion management, neuroinflammation, and longevity science brings significant clinical insight to Lionheart Health's efforts.
The appointment reinforces Lionheart Health's commitment to developing evidence-based bioelectric stimulation therapies aimed at improving cognition, memory, and mood while supporting neuroplasticity and reducing inflammation. Dr. Maroon will advise on brain health clinical study design, neurocognitive endpoint validation, and applications for concussion and neuroinflammation. He will also help translate regenerative signaling science into clinical protocols and integrate lifestyle, supplementation, and bioelectric strategies for healthspan extension.
"Dr. Maroon's decades of leadership in neurosurgery and preventive brain health bring exceptional scientific credibility and clinical insight to Lionheart Health," said Howard Leonhardt, Founder and Executive Chairman of Lionheart Health, Inc. The company's multi-modality platform includes technologies like BodStim™ and Brain Band™, which align with Dr. Maroon's focus on neuroprotection and performance longevity. Lionheart Health's intellectual property targets key regenerative pathways such as Klotho and Brain-Derived Neurotrophic Factor (BDNF), recognized for their roles in neuroplasticity and inflammation modulation.
Dr. Maroon commented on the collaboration, stating, "Optimizing brain health is central to extending meaningful healthspan. I look forward to supporting Lionheart Health's efforts to scientifically validate innovative bioelectric therapies that aim to improve neurological resilience, reduce inflammation, and enhance overall vitality." This partnership is timely as brain health represents a core pillar for Lionheart Health in the $101M XPRIZE Healthspan Competition. The company's Brain Band™ recently received a UCI Capstone Grant, and Lionheart Health has been recognized with awards including the 2025 Micro Stimulator Developer of the Year by Medtech Outlook Magazine and the Abbvie Allergan ULP Innovation Award.
Lionheart Health has completed pre-clinical studies at AccuLab Life Sciences in San Diego and a pilot clinical study in Brazil, strengthening the scientific foundation of its neuro-regenerative platform. The company is preparing to enroll participants in a clinical trial combining BodStim™ and Brain Band™ therapies, which have separately shown statistically significant improvements in brain health. Dr. Maroon's extensive background includes over 300 peer-reviewed publications and advancements in minimally invasive neurosurgical techniques, making his advisory role crucial for validating and expanding Lionheart Health's technologies. For more information, visit https://www.LionheartLongevity.com and https://www.LionheartHealthstim.com.
